Jazz Pharmaceuticals (J7Z.F) Q4 2023 Earnings

28FebConfirmed
Q4 2023
4.63
4.68
4.73
4.78

Details

Expected EPS
4.783467138320001
Actual EPS
4.6315022
Surprise EPS
-0.15
Surprise Percent
+3.18%

Description

Jazz Pharmaceuticals (J7Z.F) has reported earnings of 4.6315022 per share for Q4 2023.

0 Comments

Share your thoughts